![Sunil Agarwal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sunil Agarwal
Directeur/Membre du Conseil chez
Nesos, Inc.
Fortune : 94 676 $ au 30/06/2026
Profil
Sunil Agarwal est membre du conseil d'administration de Calithera Biosciences, Inc. et de Nesos, Inc. et directeur médical, vice-président exécutif et chef du développement chez Sana Biotechnology, Inc. Dans le cadre de sa carrière antérieure, il a été directeur médical et vice-président exécutif chez Ultragenyx Pharmaceutical, Inc, partenaire chez Sofinnova Investments, Inc, directeur chez Guilford Co, président de la recherche et du développement chez Juno Therapeutics, Inc, premier vice-président et chef mondial du développement clinique chez Genentech, Inc, directeur chez MedImmune LLC, directeur chez Kosan Biosciences, Inc et professeur adjoint de clinique à la GW School of Business. Il a obtenu un diplôme de premier cycle à l'université Cornell et un doctorat à la faculté de médecine de l'université Tufts.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ARVINAS, INC. 0,02% | 31/03/2026 | 11 393 ( 0,02% ) | 94 676 $ | 30/06/2026 |
Postes actifs de Sunil Agarwal
| Sociétés | Poste | Début |
|---|---|---|
Nesos, Inc.
 Nesos, Inc. Medical SpecialtiesHealth Technology Develops wearable ear buds and software solutions for noninvasive pain therapy | Directeur/Membre du Conseil | - |
Human Immunology Biosciences, Inc.
 Human Immunology Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing therapies for immune-mediated diseases | Directeur/Membre du Conseil | 18/04/2023 |
Norwest Venture Partners
 Norwest Venture Partners Investment ManagersFinance Norwest Venture Partners invests in companies located in North America, India and Israel. The firm focuses on companies operating across a broad range of sectors and industries.It participates in early and later stage transactions with an investment size of USD 10 - 100 million. | Private Equity Investor | 01/10/2024 |
Anciens postes connus de Sunil Agarwal
| Sociétés | Poste | Fin |
|---|---|---|
| ARVINAS, INC. | Directeur/Membre du Conseil | 24/06/2026 |
| ASTRIA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 23/01/2026 |
| SANA BIOTECHNOLOGY, INC. | Directeur Technique/Scientifique/R&D | 10/04/2023 |
| CALITHERA BIOSCIENCES, INC. | Directeur/Membre du Conseil | 01/01/2023 |
| MYOKARDIA, INC. | Directeur/Membre du Conseil | 17/11/2020 |
Formation de Sunil Agarwal
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
90
Relations au 1er degré
19
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 19 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
MedImmune LLC
 MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Kosan Biosciences, Inc.
 Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer therapeutics | Health Technology |
Astria Therapeutics, Inc.
 Astria Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel therapeutics for rare and niche allergic & immunological diseases | Health Technology |
Ultragenyx Pharmaceutical, Inc.
 Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
MyoKardia, Inc.
 MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of cardiovascular diseases | Health Technology |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Finance |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Norwest Venture Partners
Norwest Venture Partners Investment ManagersFinance Norwest Venture Partners invests in companies located in North America, India and Israel. The firm focuses on companies operating across a broad range of sectors and industries.It participates in early and later stage transactions with an investment size of USD 10 - 100 million. | Finance |
Guilford Co.
 Guilford Co. Finance/Rental/LeasingFinance Guilford Co. is a private company based in VA. | Finance |
Calithera Biosciences, Inc.
 Calithera Biosciences, Inc. BiotechnologyHealth Technology Develops novel therapeutics to control cancer and other diseases | Health Technology |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
Tufts University School of Medicine
 Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The GW School of Business
 The GW School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arvinas, Inc.
 Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
Sana Biotechnology, Inc.
 Sana Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnological company which creates and delivers engineered cells as medicine for patients | Health Technology |
Nesos, Inc.
Nesos, Inc. Medical SpecialtiesHealth Technology Develops wearable ear buds and software solutions for noninvasive pain therapy | Health Technology |
Human Immunology Biosciences, Inc.
Human Immunology Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing therapies for immune-mediated diseases | Health Technology |
Curie Bio Operations LLC
 Curie Bio Operations LLC Investment ManagersFinance Curie Bio invests in companies located in the United States. The firm targets companies operating in the fields of the biotech. It provides financing for seed stage capital requirements. | Finance |
